500 words on the DayOne Conference 2018
DayOne has a history of changing and growing each year. This year the DayOne Conference took place on 11 September, and it kept its promise and it felt like several gears were being shifted. This has to do with three factors: world relevance, innovation community engagement and patient dialogue outreach.
DayOne Conference 2018 (img: Pino Covino)
First of all, the conference ambition to reach out and connect to innovators world-wide was clearly visible. The world converged at Basel with Africa, Asia, America, Australia and Europe being represented on the podium, and Basel reached out to the world with several “local” initiatives that have the potential to bring about citizen-centricity in health-care (e.g. Oonida). Many common challenges related to access to quality health care are shared world-wide. Though the speakers and panels agreed that digital solutions are not a panacea, they offer opportunities for convergence beyond geography and, through the prism of our differences, we will benefit from mutual learning. Asia may be leading the way in online-based health services, with already 500 million connected users via Tencent, also using European techs (TenCent/ Babylon). African countries may soon be leading the way in early adoption of remote digital diagnostics. DayOne is one of the elements showing that Basel is a good place in the world to connect personalized medicine treatment developments to digital healthcare.
The second point, innovation community engagement, is that DayOne started “walking the talk“ by modelling a collaborative mode within the conference itself. Twenty-three innovators pitched their vision to the participants, who then engaged with them in as many “design-thinking” work groups. This created an engaging environment, breaking down the usual conference barriers and connecting people with diverse expertise. This is crucial since the challenges were as diverse as tough, ranging from juvenile ADHD and autism spectrum strategies to Alzheimer’s, from malaria diagnostics to personalized medicine drug testing and to open-source insurance systems.
The final take-home point, patient dialogue outreach, is probably the most important. The balance of power in healthcare may start to shift towards the patient. DayOne initiated a connection with patients as active participants in the event. Marie Ennis-O’Connor gave a voice to many patients and urged the community to “design for real patients” and engage with them “as human beings”, including “digital empathy”. And to listen, to really listen, to patients.
The starting point of innovation is reality, and our “Day 0” should be the patient.
Find more about the DayOne Conference 2018 here.
Guest article from Giovanni Nisato, edited by Catherine Nisat
DayOne focuses on the patient
The 2018 DayOne Conference – Shaping the Future of Health was held on September 11th at the Congress Centre Basel.
This was the first year as a Patients Included conference that helped to bring a stronger focus on the patient. The morning had excellent keynotes from Patient Expert Marie Ennis O’Connor, Maneesh Juneja and Bram Stieltjes and Andreas Wicki from the University Hospital Basel. These were followed with two monster panels capturing a diverse range of opinions.
The afternoon was given over to group work helping 23 projects to define their superhero story and then a final keynote from Koen Kas and recap on the day.
This year there was also a significant number of volunteer mentors and also a number of willing volunteers who helped make the day run smoothly. DayOne and the BaselArea team would like to thank them for their effort and enthusiasm.
Share this article
You might also be interested in
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More
We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.Read More